Black Diamond Therapeutics Inc (BDTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -35,258 | -8,931 | N/A | N/A | N/A |
| Depreciation Amortization | 47 | 44 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,454 | 264 | N/A | N/A | N/A |
| Other Working Capital | 463 | 354 | N/A | N/A | N/A |
| Other Operating Activity | 8,620 | -185 | 0 | 0 | 0 |
| Operating Cash Flow | $-24,674 | $-8,454 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -21 | -76 | N/A | N/A | N/A |
| Investing Cash Flow | $-21 | $-76 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 127,756 | 52,312 | 0 | 0 | 0 |
| Financing Cash Flow | $127,756 | $52,312 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 51,660 | 7,878 | N/A | N/A | N/A |
| End Cash Position | 154,721 | 51,660 | N/A | N/A | N/A |
| Net Cash Flow | $103,061 | $43,782 | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,674 | -8,454 | N/A | N/A | N/A |
| Capital Expenditure | -21 | -76 | N/A | N/A | N/A |
| Free Cash Flow | -24,695 | -8,530 | 0 | 0 | 0 |